Montana Chapter of the American College of Cardiology

Latest in Cardiology from ACC.org

• Did Disparities in ICD Implantations Worsen During the COVID-19 Pandemic? | NCDR Study
  The incidence of ICD implantations declined significantly during the COVID-19 pandemic, according to a recent study published in Heart Rhythm. Although disparities by sex, race and ethnicity persisted during peak COVID, they did not worsen.
• AFib Ablation Approaches Differ by Hospital Teaching Status | NCDR Study
  Procedural approaches for atrial fibrillation (AFib) ablation differ by hospital teaching status; however, overall complication rates are similar, according to a recent study published in JAHA.
• ACC CardiaCast: The Evolving Role of PCSK9 Inhibitors in LDL-C Management
  In this episode of CardiaCast, Dr. Michael Blaha will be joined by Dr. Ann Marie Navar to discuss the 2026 updates to ACC/AHA guideline on management of dyslipidemia and key clinical trial data supporting the use of PCSK9 inhibitors in getting patients to their lipid goals.
• Clinical Obesity Emerges as Independent Risk Factor For New-Onset HF, Mortality
  A cohort study published May 4 in JACC: Asia identified clinical obesity as a risk factor for new-onset heart failure (HF) and all-cause mortality, largely due to related clinical conditions and excess weight. Treating clinical obesity as an independent disease may increase the effectiveness of HF prevention strategies.
• ALLEPRE: Nurse-Coordinated Prevention Program May Reduce Long-Term CV Risk
  Implementing a nurse-coordinated prevention program (NCPP) significantly reduced long-term major adverse cardiovascular events (MACE) and improved body weight control, physical activity and pharmacotherapy adherence in post-hospitalization patients with acute coronary syndrome (ACS), according to results from the ALLEPRE trial published May 5 in EHJ.